Zyrtec Allergy

Manufacturer: Kenvue Brands LLC
Effective date: 2025-04-11
Label type: HUMAN OTC DRUG LABEL
Version: 17
Source: full-release
Hydrated at: 2026-06-01 00:59:02

Label at a glance#

ProductZyrtec Allergy

Active ingredientCETIRIZINE HYDROCHLORIDE

Label structure10 sections

Indications and uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat

Dosage and administration

Tablet melts in mouth. Can be taken with or without water. adults and children 6 years and over one 10 mg tablet once daily; do not take more than one 10 mg tablet in 24 hours. A 5 mg product may be appropriate for less severe symptoms. adults 65 years and over ask a doctor children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor

Storage and handling

store between 20° to 25°C (68° to 77°F). Avoid high humidity. do not use if blister unit is torn or broken

Contacts and useful links#

PhonePoison Help1-800-222-1222

PhoneLabel contact1-800-343-7805

PhoneLabel contact215-273-8755

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Cetirizine HCl 10 mg

Purpose

OTC - PURPOSE SECTION

Antihistamine

Uses

INDICATIONS & USAGE SECTION

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

runny nose
sneezing
itchy, watery eyes
itching of the nose or throat

Warnings

WARNINGS SECTION

OTC - DO NOT USE SECTION

Do not use if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine.

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.

OTC - ASK DOCTOR/PHARMACIST SECTION

Ask a doctor or pharmacist before use if you are taking tranquilizers or sedatives.

When using this product

OTC - WHEN USING SECTION

drowsiness may occur
avoid alcoholic drinks
alcohol, sedatives, and tranquilizers may increase drowsiness
be careful when driving a motor vehicle or operating machinery

OTC - STOP USE SECTION

Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.

If pregnant or breast-feeding

OTC - PREGNANCY OR BREAST FEEDING SECTION

if breast-feeding: not recommended
if pregnant: ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Directions

DOSAGE & ADMINISTRATION SECTION

Tablet melts in mouth. Can be taken with or without water.

adults and children 6 years and over	one 10 mg tablet once daily; do not take more than one 10 mg tablet in 24 hours. A 5 mg product may be appropriate for less severe symptoms.
adults 65 years and over	ask a doctor
children under 6 years of age	ask a doctor
consumers with liver or kidney disease	ask a doctor

Other information

STORAGE AND HANDLING SECTION

store between 20° to 25°C (68° to 77°F). Avoid high humidity.
do not use if blister unit is torn or broken

Inactive ingredients

INACTIVE INGREDIENT SECTION

amino methacrylate copolymer, anhydrous citric acid, colloidal silicon dioxide, crospovidone, flavors, hydroxypropyl cellulose, magnesium stearate, mannitol, microcrystalline cellulose, sodium bicarbonate, sodium starch glycolate, sucralose

Questions?

OTC - QUESTIONS SECTION

call 1-800-343-7805 (toll-free) or 215-273-8755 (collect)

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

New look

Same

relief

Original Prescription Strength

NDC 50580-778-24

ZYRTEC ^®

ALLERGY
Cetirizine HCl

orally disintegrating tablets

10 mg/antihistamine

Indoor &

Outdoor

Allergies

10 mg

Dye-Free

DISSOLVE TABS

24
Hour
Relief of

Sneezing
Runny Nose
Itchy, Watery Eyes
Itchy Throat or Nose

Actual Size

Citrus Flavor

Melts in your mouth

ORALLY

DISINTEGRATING

TABLETS

zyrtec-1

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
1011482	cetirizine HCl 10 MG Disintegrating Oral Tablet	PSN	17
1011485	ZyrTEC 10 MG Disintegrating Oral Tablet	PSN	17
1011485	cetirizine hydrochloride 10 MG Disintegrating Oral Tablet [Zyrtec]	SBD	17
1011482	cetirizine hydrochloride 10 MG Disintegrating Oral Tablet	SCD	17
1011482	cetirizine HCl 10 MG Disintegrating Oral Tablet	SY	17
1011485	Zyrtec 10 MG Disintegrating Oral Tablet	SY	17

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
CETIRIZINE Pharmacologic Class Indexing	3	Indexing - Pharmacologic Class	20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
fb7ab793-2c12-4079-b100-a64f73bef25a	Product name	4	20240712
b0cbf770-6cc3-4aa4-9158-755110c2b9f7	Product name	2	20230717
dc7c5daa-021f-40dd-b00d-63982cb2067a	Product name	1	20230426
08ffbcbf-26df-b99c-1dab-64fc4cfae89f	Product name	5	20200925
c505bb17-4ff9-45f9-ac2d-bb9c8c9d35be	Product name	1	20200304
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
a255659f-db40-429d-8c07-5f173f330d9c	Product name	1	20190402
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
08ffbcbf-26df-b99c-1dab-64fc4cfae89f	Product name	2	20160823
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
50580-778-12	Zyrtec Allergy	2 in 1 CARTON	TABLET, ORALLY DISINTEGRATING	2	17
50580-778-12	Zyrtec Allergy	6 in 1 BLISTER PACK	TABLET, ORALLY DISINTEGRATING	6	17
50580-778-24	Zyrtec Allergy	4 in 1 CARTON	TABLET, ORALLY DISINTEGRATING	4	17
50580-778-24	Zyrtec Allergy	6 in 1 BLISTER PACK	TABLET, ORALLY DISINTEGRATING	6	17
50580-778-66	Zyrtec Allergy	11 in 1 CARTON	TABLET, ORALLY DISINTEGRATING	11	17
50580-778-66	Zyrtec Allergy	6 in 1 BLISTER PACK	TABLET, ORALLY DISINTEGRATING	6	17

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50580-778	ZYRTEC ALLERGY (CETIRIZINE HYDROCHLORIDE) TABLET, ORALLY DISINTEGRATING [KENVUE BRANDS LLC]	17	Current NDC, Legacy NDC, 6 package rows	20250413_6a962a1c-c197-492b-bfa6-e0c28eda1533.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50580-778-12	EA - Each	50580-778	edad8f68-eb4b-4322-bdfe-ed5b565771ad	1	2015-01-05
50580-778-24	EA - Each	50580-778	5a2b0c49-f074-41a1-b5ac-abb39da000c4	1	2014-05-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Cetirizine Hydrochloride	ACTIVE INGREDIENT	64O047KTOA	7
Cetirizine	ACTIVE MOIETY	YO7261ME24	7
anhydrous citric acid	INACTIVE INGREDIENT	XF417D3PSL	7
cellulose, microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	7
crospovidone	INACTIVE INGREDIENT	68401960MK	7
dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer	INACTIVE INGREDIENT	905HNO1SIH	7
hydroxypropyl cellulose (type E)	INACTIVE INGREDIENT	66O7AQV0RT	7
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	7
mannitol	INACTIVE INGREDIENT	3OWL53L36A	7
silicon dioxide	INACTIVE INGREDIENT	ETJ7Z6XBU4	7
sodium bicarbonate	INACTIVE INGREDIENT	8MDF5V39QO	7
sodium starch glycolate type a potato	INACTIVE INGREDIENT	5856J3G2A2	7
sucralose	INACTIVE INGREDIENT	96K6UQ3ZD4	7

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 14 matching rows.

Zyrtec Allergy
Cetirizine Hydrochloride
ANHYDROUS CITRIC ACID
SILICON DIOXIDE
CROSPOVIDONE
HYDROXYPROPYL CELLULOSE, UNSPECIFIED
MAGNESIUM STEARATE
MANNITOL
MICROCRYSTALLINE CELLULOSE
SODIUM BICARBONATE
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER
SODIUM STARCH GLYCOLATE TYPE A
SUCRALOSE
CETIRIZINE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
50580-778	50580-778-12, 50580-778-24, 50580-778-66

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
ANHYDROUS CITRIC ACID	XF417D3PSL	IACT
SILICON DIOXIDE	ETJ7Z6XBU4	IACT
CROSPOVIDONE	2S7830E561	IACT
HYDROXYPROPYL CELLULOSE, UNSPECIFIED	9XZ8H6N6OH	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
MANNITOL	3OWL53L36A	IACT
MICROCRYSTALLINE CELLULOSE	OP1R32D61U	IACT
SODIUM BICARBONATE	8MDF5V39QO	IACT
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER	905HNO1SIH	IACT
SODIUM STARCH GLYCOLATE TYPE A	H8AV0SQX4D	IACT
SUCRALOSE	96K6UQ3ZD4	IACT
CETIRIZINE HYDROCHLORIDE	64O047KTOA	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 44 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Maximum daily exposure	Match
sucralose	SUCRALOSE	96K6UQ3ZD4	TABLET, ORALLY DISINTEGRATING / ORAL	60 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
sucralose	SUCRALOSE	96K6UQ3ZD4	TABLET, ORALLY DISINTEGRATING / ORAL	60 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
hydroxypropyl cellulose (type E)	HYDROXYPROPYL CELLULOSE (70000 WAMW)	66O7AQV0RT	CAPSULE, DELAYED RELEASE / ORAL	83 mg	Exact identifier — unii+route 12 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, ORALLY DISINTEGRATING / ORAL	68 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
hydroxypropyl cellulose (type E)	HYDROXYPROPYL CELLULOSE (70000 WAMW)	66O7AQV0RT	CAPSULE, EXTENDED RELEASE / ORAL	23 mg	Exact identifier — unii+route 12 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	TABLET, ORALLY DISINTEGRATING / ORAL	107 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, ORALLY DISINTEGRATING / ORAL	68 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
hydroxypropyl cellulose (type E)	HYDROXYPROPYL CELLULOSE (70000 WAMW)	66O7AQV0RT	CAPSULE, EXTENDED RELEASE / ORAL	23 mg	Exact identifier — unii+route 12 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, ORALLY DISINTEGRATING / ORAL	1800 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
hydroxypropyl cellulose (type E)	HYDROXYPROPYL CELLULOSE (70000 WAMW)	66O7AQV0RT	CAPSULE, EXTENDED RELEASE / ORAL	23 mg	Exact identifier — unii+route 12 equally ranked IID candidates
sucralose	SUCRALOSE	96K6UQ3ZD4	TABLET, ORALLY DISINTEGRATING / ORAL	60 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, ORALLY DISINTEGRATING / ORAL	1800 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
anhydrous citric acid	ANHYDROUS CITRIC ACID	XF417D3PSL	TABLET, ORALLY DISINTEGRATING / ORAL	46 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
mannitol	MANNITOL	3OWL53L36A	TABLET, ORALLY DISINTEGRATING / ORAL	4364 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
anhydrous citric acid	ANHYDROUS CITRIC ACID	XF417D3PSL	TABLET, ORALLY DISINTEGRATING / ORAL	46 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET, ORALLY DISINTEGRATING / ORAL	187 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER	905HNO1SIH	TABLET, ORALLY DISINTEGRATING / ORAL	222 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET, ORALLY DISINTEGRATING / ORAL	187 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
hydroxypropyl cellulose (type E)	HYDROXYPROPYL CELLULOSE (70000 WAMW)	66O7AQV0RT	TABLET, FILM COATED / ORAL	15 mg	Exact identifier — unii+route 12 equally ranked IID candidates
mannitol	MANNITOL	3OWL53L36A	TABLET, ORALLY DISINTEGRATING / ORAL	4364 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	TABLET, ORALLY DISINTEGRATING / ORAL	107 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, ORALLY DISINTEGRATING / ORAL	68 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
hydroxypropyl cellulose (type E)	HYDROXYPROPYL CELLULOSE (70000 WAMW)	66O7AQV0RT	CAPSULE, DELAYED RELEASE / ORAL	83 mg	Exact identifier — unii+route 12 equally ranked IID candidates
anhydrous citric acid	ANHYDROUS CITRIC ACID	XF417D3PSL	TABLET, ORALLY DISINTEGRATING / ORAL	46 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
hydroxypropyl cellulose (type E)	HYDROXYPROPYL CELLULOSE (70000 WAMW)	66O7AQV0RT	CAPSULE, DELAYED RELEASE / ORAL	83 mg	Exact identifier — unii+route 12 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	TABLET, ORALLY DISINTEGRATING / ORAL	107 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER	905HNO1SIH	TABLET, ORALLY DISINTEGRATING / ORAL	222 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
hydroxypropyl cellulose (type E)	HYDROXYPROPYL CELLULOSE (70000 WAMW)	66O7AQV0RT	CAPSULE, DELAYED RELEASE / ORAL	83 mg	Exact identifier — unii+route 12 equally ranked IID candidates
mannitol	MANNITOL	3OWL53L36A	TABLET, ORALLY DISINTEGRATING / ORAL	4364 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
hydroxypropyl cellulose (type E)	HYDROXYPROPYL CELLULOSE (70000 WAMW)	66O7AQV0RT	TABLET, FILM COATED / ORAL	15 mg	Exact identifier — unii+route 12 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	TABLET, ORALLY DISINTEGRATING / ORAL	107 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER	905HNO1SIH	TABLET, ORALLY DISINTEGRATING / ORAL	222 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, ORALLY DISINTEGRATING / ORAL	68 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
hydroxypropyl cellulose (type E)	HYDROXYPROPYL CELLULOSE (70000 WAMW)	66O7AQV0RT	TABLET, FILM COATED / ORAL	15 mg	Exact identifier — unii+route 12 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET, ORALLY DISINTEGRATING / ORAL	187 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, ORALLY DISINTEGRATING / ORAL	1800 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET, ORALLY DISINTEGRATING / ORAL	187 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
hydroxypropyl cellulose (type E)	HYDROXYPROPYL CELLULOSE (70000 WAMW)	66O7AQV0RT	CAPSULE, EXTENDED RELEASE / ORAL	23 mg	Exact identifier — unii+route 12 equally ranked IID candidates
anhydrous citric acid	ANHYDROUS CITRIC ACID	XF417D3PSL	TABLET, ORALLY DISINTEGRATING / ORAL	46 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
mannitol	MANNITOL	3OWL53L36A	TABLET, ORALLY DISINTEGRATING / ORAL	4364 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
hydroxypropyl cellulose (type E)	HYDROXYPROPYL CELLULOSE (70000 WAMW)	66O7AQV0RT	TABLET, FILM COATED / ORAL	15 mg	Exact identifier — unii+route 12 equally ranked IID candidates
sucralose	SUCRALOSE	96K6UQ3ZD4	TABLET, ORALLY DISINTEGRATING / ORAL	60 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, ORALLY DISINTEGRATING / ORAL	1800 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER	905HNO1SIH	TABLET, ORALLY DISINTEGRATING / ORAL	222 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N022578-001	ZYRTEC ALLERGY	CETIRIZINE HYDROCHLORIDE	10MG	TABLET, ORALLY DISINTEGRATING / ORAL		RLD, RS	2010-09-03

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N022578-001	ZYRTEC ALLERGY	10MG	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2010-09-03	`f41ea6bd6efb…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Zyrtec Allergy	CETIRIZINE HYDROCHLORIDE	Kenvue Brands LLC	6a962a1c-c197-492b-bfa6-e0c28eda1533	2025-04-11	Warnings	Exact identifier ndc (package): 50580-778-12 ndc (package): 50580-778-24 ndc (package): 50580-778-66 ndc (product): 50580-778 ndc11 (package): 50580077824 ndc11 (package): 50580077866 ndc11 (package): 50580077812 spl id: 3254957b-3bb2-98a9-e063-6394a90a9358 spl set id: 6a962a1c-c197-492b-bfa6-e0c28eda1533

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.